Strides Pharma Science is preparing to enhance its presence in Sub-Saharan Africa by acquiring branded generic products from Sandoz AG, wit...

Resolution of the US drug price fixing probe will remove a major overhang on the stock.

Taking Sandoz out of estimates, the brokerage now expects consolidated revenue growth in mid-single digit for Aurobindo over the next two y...

Brokerages see the termination of the deal as a setback to scale up sales in the US .

The brokerage has reduced its earnings estimate for FY21/FY22 by 19 per cent/18 per cent to Rs 51/Rs 53 to factor in termination of Sandoz ...

The transaction if completed would have positioned the Hyderabad-based firm as the second largest dermatology player and the second largest...

Novartis AG on Thursday scrapped the $1 billion sale of U.S. generic pill and skin drug assets to India's Aurobindo Pharma Ltd as regulator...

In September last year, the USD three billion drug maker said its US subsidiary entered into an agreement to acquire commercial operations ...

The company is still resolving issues with US Free Trade Commission for the Sandoz acquisition.

On Wednesday, shares of Aurobindo closed 4.8 per cent lower at Rs 450.75 on the BSE.

Aurobindo Pharma Ltd. to invest $ 200 million on Capex and over 5% of sale value on R&D.

Buy Aurobindo Pharma Ltd. at a price target of Rs 836.

The acquired business has been carved out by the management of Sandoz for divestment.

The acquisition will add approximately 300 products including projects in development as well as commercial and manufacturing capabilities ...

Under the terms of the agreement, both companies will share responsibility for end to end development, manufacturing and global regulatory ...

Sun Pharmaceutical announced it received approval from the US FDA for generic copies of Gleevec, a drug that treats chronic myeloid leukemi...

The decision by the Supreme Court comes at a time when Teva is switching its daily version of Copaxone to twice a week version.